drugset / Trial / NCT01104532

A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects

NCT01104532

Phase 1 Completed 64 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to evaluate pharmacokinetics, pharmacodynamics and safety following the administration of ASP1941 and sitagliptin in single and multiple doses.

Timeline

Start
2010-02
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule Oral
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.